These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

103 related articles for article (PubMed ID: 4815964)

  • 1. The assay of phenylbutazone in human plasma by a specific and sensitive gas-liquid chromatographic procedure.
    McGilveray IJ; Midha KK; Brien R; Wilson L
    J Chromatogr; 1974 Feb; 89(1):17-22. PubMed ID: 4815964
    [No Abstract]   [Full Text] [Related]  

  • 2. Simultaneous determination of phenylbutazone and oxyphenbutazone in plasma by high-speed liquid chromatography.
    Pound NJ; Sears RW
    J Pharm Sci; 1975 Feb; 64(2):284-7. PubMed ID: 1127584
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Oxyphenbutazone and phenylbutazone determination in plasma and urine by GLC.
    Bruce RB; Maynard WR; Dunning LK
    J Pharm Sci; 1974 Mar; 63(3):446-8. PubMed ID: 4820382
    [No Abstract]   [Full Text] [Related]  

  • 4. Simultaneous determination of phenylbutazone and its metabolites in plasma and urine by high-performance liquid chromatography.
    Marunaka T; Shibata T; Minami Y; Umeno Y
    J Chromatogr; 1980 Sep; 183(3):331-8. PubMed ID: 7419650
    [TBL] [Abstract][Full Text] [Related]  

  • 5. GLC determination of plasma concentration of phenylbutazone and its metabolite oxyphenbutazone.
    Midha KK; McGilveray IJ; Charette C
    J Pharm Sci; 1974 Aug; 63(8):1234-9. PubMed ID: 4852201
    [No Abstract]   [Full Text] [Related]  

  • 6. Solid-phase extraction for the high-performance liquid chromatographic determination of indomethacin, suxibuzone, phenylbutazone and oxyphenbutazone in plasma, avoiding degradation of compounds.
    Caturla MC; Cusido E
    J Chromatogr; 1992 Oct; 581(1):101-7. PubMed ID: 1429991
    [TBL] [Abstract][Full Text] [Related]  

  • 7. A supercritical fluid chromatographic method using packed columns for phenylbutazone and oxyphenbutazone in serum, and for phenylbutazone in a dosage form.
    Simmons BR; Jagota NK; Stewart JT
    J Pharm Biomed Anal; 1995 Jan; 13(1):59-64. PubMed ID: 7718635
    [TBL] [Abstract][Full Text] [Related]  

  • 8. [Determination of bumadizone, phenylbutazone and oxyphenbutazone in human plasma by high-performance liquid chromatography (author's transl)].
    Spahn H; Mutschler E
    Arzneimittelforschung; 1981; 31(3):495-9. PubMed ID: 6894379
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Separation of furosemide, phenylbutazone and oxyphenbutazone in plasma by direct injection onto internal surface reversed-phase columns with systematic optimization of selectivity.
    Pinkerton TC; Perry JA; Rateike JD
    J Chromatogr; 1986 Oct; 367(2):412-8. PubMed ID: 3782354
    [No Abstract]   [Full Text] [Related]  

  • 10. Screening, quantification, and confirmation of phenylbutazone and oxyphenbutazone in equine plasma by liquid chromatography-tandem mass spectrometry.
    You Y; Uboh CE; Soma LR; Guan F; Li X; Rudy JA; Chen J
    J Anal Toxicol; 2009; 33(1):41-50. PubMed ID: 19161668
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Determination of phenylbutazone and oxyphenbutazone in plasma and urine samples of horses by high-performance liquid chromatography and gas chromatography-mass spectrometry.
    Neto LM; Andraus MH; Salvadori MC
    J Chromatogr B Biomed Appl; 1996 Apr; 678(2):211-8. PubMed ID: 8738024
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Quantitative determination of plasma oxyphenbutazone by gas-liquid chromatography with selective nitrogen detection.
    Bertrand M; Dupuis C; Gagnon MA; Dugal R
    J Chromatogr; 1979 Apr; 171():377-83. PubMed ID: 546857
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Effect of albumin conformation on binding of phenylbutazone and oxyphenbutazone to human serum albumin.
    Abd Elbary A; Vallner JJ; Whitworth CW
    J Pharm Sci; 1982 Feb; 71(2):241-4. PubMed ID: 7062254
    [TBL] [Abstract][Full Text] [Related]  

  • 14. [Comparison of bumadizone-, phenylbutazone- and oxyphenbutazone-plasma levels after a single oral dose of phenylbutazone and of bumadizone, respectively (author's transl)].
    Spahn H; Mutschler E; Geissler HE; Faust-Tinnefeldt G
    Arzneimittelforschung; 1981; 31(3):499-503. PubMed ID: 6894380
    [TBL] [Abstract][Full Text] [Related]  

  • 15. GLC determination of gamma-hydroxyphenylbutazone in plasma.
    Midha KK; McGilveray IJ; Charette C
    J Pharm Sci; 1974 Nov; 63(11):1751-4. PubMed ID: 4427237
    [No Abstract]   [Full Text] [Related]  

  • 16. Mechanisms of inhibition of tolbutamide metabolism: phenylbutazone, oxyphenbutazone, sulfaphenazole.
    Pond SM; Birkett DJ; Wade DN
    Clin Pharmacol Ther; 1977 Nov; 22(5 Pt 1):573-9. PubMed ID: 913025
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Gas chromatographic and high resolution mass spectrometric determination of phenylbutazone in blood.
    Sabih K
    Biomed Mass Spectrom; 1974 Aug; 1(4):252-5. PubMed ID: 4441619
    [No Abstract]   [Full Text] [Related]  

  • 18. Analysis of phenylbutazone in plasma by high-speed liquid chromatography.
    Pound NJ; McGilveray IJ; Sears RW
    J Chromatogr; 1974 Feb; 89(1):23-30. PubMed ID: 4815966
    [No Abstract]   [Full Text] [Related]  

  • 19. Specimen handling in an HPLC determination of phenylbutazone and its major metabolites in plasma, avoiding degradation of the compounds.
    Franssen MJ; Tan Y; Freij I; Van Ginneken CA; Gribnau FW
    Pharm Weekbl Sci; 1986 Aug; 8(4):229-33. PubMed ID: 3763367
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Comparative pharmacokinetics of phenylbutazone and its metabolite oxyphenbutazone in clinically normal horses and donkeys.
    Mealey KL; Matthews NS; Peck KE; Ray AC; Taylor TS
    Am J Vet Res; 1997 Jan; 58(1):53-5. PubMed ID: 8989496
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.